Calliditas Therapeutics AB (publ)
Calliditas Therapeutics AB (publ) (CALT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CALT · as of Jun 9, 2026
Key Statistics
Explore Calliditas Therapeutics AB (publ) Data
calt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 0.0%
The CALT analyst consensus is Hold, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $39.50, representing -1.25% downside from the current price of $40.00.
Competitors & Peers
calt competitorsCALT
AMAM
BLU
DCPH
DICE
FUSNStock Performance
Full HistoryAbout Calliditas Therapeutics AB (publ)
Calliditas Therapeutics AB (publ) operates as a clinical-stage biopharmaceutical entity, committed to identifying, advancing, and commercializing therapeutic products. Its primary focus lies in develo…
what is calliditas therapeutics ab (publ) · calt stock overview · calliditas therapeutics ab (publ) company profile · who is calliditas therapeutics ab (publ) ceo · calt NASDAQ · calliditas therapeutics ab (publ) headquarters · calliditas therapeutics ab (publ) business segments
About Stock Overview & Key Data
Calliditas Therapeutics AB (publ) (CALT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 5, 2020. As of the latest trading session, CALT stock price is $40.00, with a market capitalization of $2.1B. The stock has returned +129.16% over the past 12 months and +60.00% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Calliditas Therapeutics AB (publ) stock is Hold, with an average 12-month price target of $39.50. In fiscal year 2023, Calliditas Therapeutics AB (publ) reported revenue of $1.2B and net income of -$466.2M. For detailed data — including Calliditas Therapeutics AB (publ) revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Calliditas Therapeutics AB (publ) (CALT) stock price is $40.00. The stock is traded on NASDAQ under the ticker symbol CALT. The 52-week range is $15.25 – $43.00.